Skip to main content

Novavax’s stock pops after WHO grants its COVID-19 vaccine emergency-use listing

Novavax's protein-based vaccine can now be offered to all 194 member nations of the WHO, as well as Unicef and other agencies.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.